A Study of MM-121 in Combination With Chemotherapy Versus Chemotherapy Alone in Heregulin Positive NSCLC
Stopped Based on the preliminary results seen during interim analysis, which were confirmed in the final analysis, the Sponsor terminated the study
Conditions
- Non-Small Cell Lung Cancer
- NSCLC
- Adenocarcinoma
- Heregulin
Interventions
- DRUG: MM-121
- DRUG: Docetaxel
Sponsor
Elevation Oncology
Collaborators